Medication-related osteonecrosis of the jaw: current theoretical and useful concepts for the general practitioner
DOI:
https://doi.org/10.59334/ROV.v2i29.145Keywords:
Osteonecrosis of the jaw, antiresorptive drug, bisphosphonates, Denosumab, surgical wound infection, dental extractionAbstract
Medication-related osteonecrosis of the jaw (MRONJ) is a syndrome associated to the use of antiresorptive therapy (bisphosphonates), RANK-ligand inhibitors and angiogenesis inhibitors drugs, used for the treatment of cancer and osteoporosis among other diseases.
Purpose: Update the knowledge on its etiopathogenesis emphasizing the role of infection, and in doing so, look for treatments that can be carried out by general practitioners.
Materials and methods: A scoping review is performed through Medline (Pubmed) and Cochrane databases, of articles published from to 2010, in English and Spanish, including MeSH keywords such as “osteonecrosis of the jaw; “antiresorptive drug”; “bisphosphonates”; “Denosumab”; “surgical wound infection”; “dental extraction”.
Conclusions: The current evidence demonstrate that, taking into account individual risk factors, teeth extractions can be harmless performed in patients under antiresorptive or antiangiogenic interetherapies because the origin of MRONJ appears to be more related to biofilm contamination than with the use or effects of any specific drug. Once MRONJ is installed, surgical therapies prove to be more effective in the treatment and remission of these lesions.
Downloads
References
Arbildo-Vega A, Chumpitaz-Durand R, Vidal-Mosquera A. (2014). Osteonecrosis de los maxilares relacionado con el tratamiento con bifosfonatos. Una revision. KIRU. Ene-Jun;11 (1):90-100.
Albu-Stan IA, Albu DE, Cerghizan D, Eremie LY, Janosi K, Balos M, Copotolu C. (2017). Medication-related osteonecrosis of the jaw: a brief review, treatment and practical guidelines for Dentist. Journal of Interdisciplinary Medicine. 2(2):117-121. https://doi.org/10.1515/jim-2017-0046
Aguirre J. (2010). Effects of alendronate on bone healing after tooth extraction in rats. Oral Dis.; (16):674-85. https://doi.org/10.1111/j.1601-0825.2010.01677.x
Agarwal P, Rao N. (2012). Bisphosphonate-associated osteonecrosis of the jaws. Indian J Dentist Res.; 23: 107-11. https://doi.org/10.4103/0970-9290.99051
Beth-Tasdogan NH, Mayer B, Hussein H, Zolk O. (2016). Interventions for managing medication-related osteonecrosis of the jaw (MRONJ). Cochrane Database of Systematic Reviews Protocol. Issue 11. Art. No.: CD012432. DOI: 10.1002/14651858.CD012432. https://doi.org/10.1002/14651858.CD012432
Crincoli V, Ballini A, Di Comite M, Tettamanti L, Coscia MF, Mastrangelo F, et al. (2015). Microbiological investigation of medication-related osteonecrosis of the jaw: preliminary results. Journal of Biological regulators and homeostatic agents. Vol 29 no4, 977-983.
Damm DD, Jones DM. (2013). Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays. Gen Dent. 61:33.
Filleul O, Crompot S, Saussez S. (2010). Biphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol. Aug;136(8):1117-24. https://doi.org/10.1007/s00432-010-0907-7
Fliefel R, Trölzsch M, Kühnisch J, Ehrenfield M, Otto S. (2015). Treatments strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review. Int J Oral Maxillofac Surg. 44: 568-585. https://doi.org/10.1016/j.ijom.2015.01.026
Fernández E, González H, Castro A, Lisboa D. (2015). Osteología: relevancia de conceptos médicos en el ámbito odontológico. Rev Clin Periodoncia Implantol Rehabil Oral. 8(1):83-92. https://doi.org/10.1016/j.piro.2015.02.010
Gaudin E, Seidel I, Bacevic M, Rompen E, Lambert F. (2015). Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol. 42: 922–932. https://doi.org/10.1111/jcpe.12455
Girbone J, Catagnetto P. (2013). Osteonecrosis de los maxilares inducida por bifosfonatos; lo que el odontólogo debe saber hoy: pautas y protocolos. Odontoestomatología. 15(21). 45-58.
Guazzo R, Sbricoli L, Ricci s, Bressan E, Piatelli A, Iaculli F. (2017). Medication-related osteonecrosis of the jaw and dental implant failures: a systematic review. Journal of Oral Imlantology. Vol 43 Nº1. https://doi.org/10.1563/aaid-joi-16-00057
Heufelder M, Remmerbach T, Hemprich A. (2014). Principles of oral surgery for prevention of bisphosphonates-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol. Jun;117(6):e429-35. https://doi.org/10.1016/j.oooo.2012.08.442
Hellstein JW, Adler RA, Edwards B et al. (2011). Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 142:1243–1251. https://doi.org/10.14219/jada.archive.2011.0108
Hasegawa T, Kawakita A, Ueda N, Funahara R, Tachibana A, Kobayashi M, et al. (2017). A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and drug holiday really prevent MRONJ? Osteoporos Int. 28:2465-2473. https://doi.org/10.1007/s00198-017-4063-7
Kim YH, Lee HK, Song SI, Lee JK. (2014). Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw. Journal of the Korean Association of Oral and Maxillofacial Surgeons. 40(5):206-210. https://doi.org/10.5125/jkaoms.2014.40.5.206
Khan A, Morrison A, Hanley D, Felsenberg D, McCauley L, O’Ryan F, Reid, I et al. (2015). Diagnosis and Management of Osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. Jan;30(1):3-23. https://doi.org/10.1002/jbmr.2405
Katsarelis H, Shah NP, Dhariwal DK, Pazianas M. (2015). Infection and medication-related osteonecrosis of the jaw. J Dent Res. 94: 534–539. https://doi.org/10.1177/0022034515572021
Khan A, Morrison A, Cheung A, Hashem W, Compston. (2016). Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015. Osteoporos Int. Mar;27(3):853-859. https://doi.org/10.1007/s00198-015-3335-3
Kim HY, Kim JW, Kim SJ, Lee SH, Lee HS. (2017). Uncertainty of current algorithm for bisphosphonate-relates Osteonecrosis of the jaw in population-based studies: a systematic review. J Bone Miner Res. Mar; 32(3): 584-591. https://doi.org/10.1002/jbmr.3017
Kim KM, Rhee Y, Kwon YD, Kwon TG, Lee JK, Kim DY. (2015). Medication Related Osteonecrosis of the Jaw: 2015 Position Statement of the Korean Society for Bone and Mineral Research and the Korean Association of Oral and Maxillofacial Surgeons. J Bone Metab. Nov; 22(4):151-65. https://doi.org/10.11005/jbm.2015.22.4.151
Lerner UH. Biología del remodelado óseo en los maxilares con y sin dientes. En: Textbook of removable prosthodontics. The Scandinavian approach. 1th ed AMOLCA; 2014. p. 51-60.
Migliorati CA, Saunders D, Conlon MS, Ingstad HK, Vaagen P, Palazzolo MJ, et ál. (2013). Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction. J Am Dent Assoc. 144: 406e414. https://doi.org/10.14219/jada.archive.2013.0134
Mupparapu, M. (2016). Editorial: Medication-related osteonecrosis of the jaw (MRONJ): Bisphosphonates, antiresorptives, and antiangiogenic agents. What next? Quintessence Int. Jan; 47(1):7-8. https://doi.org/10.3290/j.qi.a35303
Mozzati M, Arata V, Gallesio G. (2013). Tooth extraction in osteoporotic patients taking oral bisphosphonates. Osteoporos Int. 24: 1707-12. https://doi.org/10.1007/s00198-012-2239-8
Matsumoto A, Masanori S, Rainer S, Yukiko O, Yoshihide M, Pit Jacob V. (2017). Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab. Clin Oral Investig. Jan 29; 21(1): 127-134. https://doi.org/10.1007/s00784-016-1762-y
Niibe K, Ouchi T, Iwasaki R, Nakagawa T, Horiee N. (2015). Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab. Journal of Prosthodontic research. 59: 3-4. https://doi.org/10.1016/j.jpor.2014.08.001
Otto S, Trölzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfield M, Pautke C. (2015). Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development? Journal of Cranio-maxillo-facial Surgery: Official Publication of the European Association for Cranio-Maxillo-Facial Surgery. 43(6):847-854. https://doi.org/10.1016/j.jcms.2015.03.039
Poxleitner P, Englehardt M, Schmelzeisen R, Voss P. (2017). The prevention of medication-related osteonecrosis of the jaw. Dtsch Arztebl Int. 114:63-9. https://doi.org/10.3238/arztebl.2017.0063
Rupel K, Ottaviani G, Gobbo M, Contardo M, Tirelli G, Vescovi P, et ál. (2014). A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ). Oral Oncol. Nov; 50(11): 1049-57. https://doi.org/10.1016/j.oraloncology.2014.08.016
Ruggiero S, Dodson T, Fantasia J, Goodday R, Aghaloo T, Mehrota B, O’Ryan F. (2014). American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update. J Oral Maxillofac Surg. 72:1938-1956, 2014. https://doi.org/10.1016/j.joms.2014.04.031
Rosella D, Papi P, Giardi no R, Cicalini E, Piccoli L, Pompa G. (2016). Medication-related osteonecrosis of the jaw: Clinical and practical guidelines. J Int Soc Prevent Communit Dent. 6:97-104. https://doi.org/10.4103/2231-0762.178742
Saia G, Blandamuera S, Bettini G, Tronchet A, Totola A, Bedogni G, et ál. (2010). Occurrence of Bisfphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. 2010. J Oral Maxillofac Surg. 68:797-804. https://doi.org/10.1016/j.joms.2009.10.026
Silva LF, Curra C, Munerato MS, Deantoni CC, Matsumoto MA, Cardoso CL, Curi, MM. (2016). Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review. Oral Maxillofac Surg. Mar;20(1):9-17. https://doi.org/10.1007/s10006-015-0538-x
Vera-Sirera B, Pellín-Carcelen A, Vera-Sempere F. (2012). Osteonecrosis maxilar relacionada con bifosfonatos (OMRB): consideraciones patogénicas con posibles implicaciones terapéuticas. Rev Esp Cir Oral Maxilofac. 34 (2):94-95. https://doi.org/10.1016/j.maxilo.2011.07.002
Valour F, Sénéchal A, Dupieux C, Karsenty J, Lustig S, Breton P, et ál. (2014). Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. Infect Drug Resist. Jul 5;7:183-97. https://doi.org/10.2147/IDR.S39601
Vatsa A, Breuls RG, Semeins CM, Salmon PL, Smit TH, Klein-Nulend J. (2008). Osteocyte morphology in fibula and calvaria - is there a role for mechanosensing? Bone. Sep;43(3):452-8. https://doi.org/10.1016/j.bone.2008.01.030
Wagner G, Gorby Y, El-Naggar M, Yuzvinsky T, Schaudinn C, Gorur A et ál. (2013). Electrically conductive bacterial nanowires in bisphosphonate-related osteonecrosis of the jaw biofilms. Oral and maxillofacial pathology. Vol 115. Nº1. 71-78. https://doi.org/10.1016/j.oooo.2012.08.446
World Health Organization. Worldwide country situation analysis: response to antimicrobial resistance. 2015. 29 April. ISBN: 9789241564946. http://apps.who.int/iris/bitstream/10665/163468/1/9789241564946_eng.pdf
Zahid TM, Wang BY, Cohen RE. (2011). Influence of Biphosphonates on alveolar bone loss around osseointgrated implants. Journal of Oral Implantology. Vol 35 Nº3. https://doi.org/10.1563/AAID-JOI-D-09-00114
Downloads
Published
Issue
Section
License
Copyright (c) 2018 Enrique Fernández, Paula Padilla, Christopher Reyes, David Lisboa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Odontología Vital agree to the following terms:
- Authors retain the copyright and grant Universidad Latina de Costa Rica the right of first publication, with the work simultaneously licensed under a Creative Commons Attribution 4.0 International license (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the Odontología Vital's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
